<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">446</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">589-590</td>
    </tr>
</table>

<br/><b>Description</b><br/>
This data item is used to count the number of tumors (multiplicity) that are reported as a single primary, when present at the time of diagnosis or occurring later.

<br/><br/><b>Rationale</b><br/>
Patients with multiple tumors reported as a single primary for surveillance purposes may have a worse prognosis or more extensive treatment than patients with a single tumor. This data item will make it possible to identify important information about these cases for data analysis.

<br/><br/><b>Codes (refer to <a href="http://seer.cancer.gov/tools/mphrules/index.html" target="_blank">http://seer.cancer.gov/tools/mphrules/index.html</a> for additional instructions).</b><br/>
<table class="naaccr-codes-table">
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">00</td>
        <td class="naaccr-codes-cell">No primary tumor identified</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">01</td>
        <td class="naaccr-codes-cell">One tumor only</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">02</td>
        <td class="naaccr-codes-cell">Two tumors present; bilateral ovaires involved with cystic carcinoma</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">03</td>
        <td class="naaccr-codes-cell">Three tumors present</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap" colspan="2">..</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap" colspan="2">..</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">88</td>
        <td class="naaccr-codes-cell">Information on multiple tumors not collected/not applicable for this site</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">89</td>
        <td class="naaccr-codes-cell">Multicentric, multifocal, number unknown</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">99</td>
        <td class="naaccr-codes-cell">Unknown if multiple tumors; not documented</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">Blank</td>
        <td class="naaccr-codes-cell">Information not collected for this diagnosis date (e.g., all cases diagnosed prior to 2007)</td>
    </tr>
</table>
<br/><br/><i>Note</i>: Codes 00 and 89 were added effective for 2011.
